Oncology
Solid tumours and haematological malignancies, from early-phase dose-finding to pivotal studies, supported by recruitment strategies for narrowly defined patient populations.
Our teams combine clinical knowledge with relationships at leading centres, so studies start faster and run smoothly.
Solid tumours and haematological malignancies, from early-phase dose-finding to pivotal studies, supported by recruitment strategies for narrowly defined patient populations.
Heart failure, hypertension, arrhythmia and interventional cardiology, including device and drug-device combination studies.
Retinal disease, glaucoma and anterior-segment studies with experienced investigators and standardised imaging and endpoint procedures.
Chronic kidney disease, dialysis and transplant studies, including long-term follow-up and safety monitoring.
Benign and oncologic urology, urinary incontinence and men's health, in both drug and medical-device programmes.
Bacterial, viral and fungal infections and vaccines, with rapid site activation for time-sensitive enrolment.
Implants, biologics and rehabilitation research, including post-market clinical follow-up for orthopaedic devices.
Surgical devices, wound care and peri-operative studies run with high-volume surgical centres.
Studies in children and adolescents, with ethics-led study design, family-centred consent processes and paediatric-experienced investigators.
We regularly extend into new areas through our investigator network. Talk to us about your programme.